Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...
MedPage Today on MSN
FDA approves at-home device for treatment-resistant depression
The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...
At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant depression. It’s called SAINT, and here’s how it works.
We preselected all newsletters you had before unsubscribing.
The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...
Hosted on MSN
US FDA approves first at-home device to treat depression – here’s what you need to know
The U.S. Food and Drug Administration has cleared an at-home brain stimulation headset developed by Flow Neuroscience to help treat depression, giving patients another option beyond standard ...
Flow Neuroscience is working with outpatient clinics in London’s Harley Street district in a partnership that will see its brain stimulation headset be offered to patients as an add-on treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results